等级
certified reference material
TraceCERT®
产品线
TraceCERT®
CofA
current certificate can be downloaded
包装
ampule of 1 mL
浓度
2000 μg/mL in methanol
技术
HPLC: suitable
gas chromatography (GC): suitable
应用
environmental
包装形式
single component solution
储存温度
2-8°C
InChI
1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3
InChI key
XEKOWRVHYACXOJ-UHFFFAOYSA-N
一般描述
在硫酸存在的条件下，可通过乙醇与乙酸发生酯化反应获得乙酸乙酯。它可作为溶剂应用于油墨、清漆、油脂、硝化纤维的生产。此外，也可用于纺织的清洗剂以及食品和医药工业的调味剂。它也可在食品工业中用作甲基乙基酮的替代物。
应用
有关合适的仪器技术的更多信息，请参阅产品′的检验报告。想要获得更多支持，请联系技术服务部。
其他说明
该认证标准物质（CRM）根据ISO 17034和ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在检验报告上找到。
法律信息
TraceCERT is a registered trademark of Merck KGaA, Darmstadt, Germany
警示用语：
Danger
危险分类
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
靶器官
Eyes
储存分类代码
3 - Flammable liquids
WGK
WGK 1
闪点(°F)
51.8 °F - closed cup
闪点(°C)
11 °C - closed cup
个人防护装备
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
法规信息
危险化学品
此项目有
Aerobic oxidation of aqueous ethanol using heterogeneous gold catalysts: Efficient routes to acetic acid and ethyl acetate
J?rgensen B, et al.
J. Catal., 251, 332-337 (2007)
Stellman, MJ
Encyclopaedia of Occupational Health and Safety: Guides, indexes, directory (1998)
Prabhakar Kumar Verma et al.
Pakistan journal of pharmaceutical sciences, 26(1), 209-215 (2012-12-25)
A rapid resolution high performance thin layer chromatography (HPTLC) method has been developed and validated for estimation of olmesartan medoxomil in tablet formulations. This paper describes accurate, precise, specific and reproducible method and its degradation products, related impurities for assessment
Madhu Chandel et al.
Asian Pacific journal of tropical medicine, 5(12), 977-985 (2012-12-04)
To evaluate the antioxidant potential of different extract/fractions of Anthocephalus cadamba (A. cadamba) (Roxb.) Miq. (Rubiaceae) and study the tentative identification of their active constituents. The extract/fractions were screened for antioxidant activity using various in vitro assays viz. DPPH assay
Yuusuke Fujimoto et al.
PloS one, 7(11), e48685-e48685 (2012-11-13)
Combination therapy with ribavirin, interferon, and viral protease inhibitors could be expected to elicit a high level of sustained virologic response in patients infected with hepatitis C virus (HCV). However, several severe side effects of this combination therapy have been
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持